Synthomer plc

Synthomer plc

1.38
EUR
-0.03
(-2.13%)
120.06MMarket Cap
Mar 04Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
20.1
18.95
17.61
21.16
29.94
32.76
27.32
28.51
36.54
36.76
22.73
11.83
10.64
- -
Basic EPS, GAAP
0.98
0.92
1.22
2.23
1.5
2.02
1.58
0.05
3.56
-0.51
-0.78
-0.44
-0.96
- -
Free Cash Flow per Basic Share
0.54
0.85
1.5
1.84
1.44
0.44
1.55
2.31
3.26
0.68
0.77
-0.76
0.22
- -
Dividend per Share
0.39
0.45
1.09
0.61
0.79
0.86
0.9
0.22
1.25
1.57
- -
- -
- -
- -
Book Value per Share
5.88
5.39
5.05
6.6
7.85
9.39
11.26
10.66
16.07
16.03
7.02
6.68
5.51
5.51
Tangible Book Value per Share
-1.23
-0.97
-0.49
-0.6
-0.19
1.08
4.27
-4.44
2.97
-0.76
0.97
0.98
0.25
0.25
Basic Weighted Avg Shares
49
49
49
49
49
49
53
58
59
63
85
163
164
164
Sales/Revenue/Turnover
993
936
870
1,046
1,480
1,619
1,459
1,644
2,144
2,332
1,941
1,933
1,739
- -
Operating Margin (%)
7.37
6.98
8.67
9.68
7.25
7.57
7.96
9.58
18.66
5.27
-2.04
97.67
97.45
- -
Depreciation Expense
46
47
46
57
68
55
52
70
101
94
105
96
99
- -
Net Income, GAAP
48
45
60
110
74
100
85
3
209
-32
-67
-73
-157
- -
Effective Tax Rate (%)
16.07
13.94
12.97
11.27
13.43
14.13
14.83
107.39
27.14
- -
- -
- -
- -
- -
Profit Margin (%)
4.87
4.84
6.94
10.56
5
6.16
5.8
0.19
9.73
-1.39
-3.45
-3.76
-9.03
- -
Working Capital
48
63
25
97
56
85
123
168
512
582
463
271
251
251
LT Debt
161
137
74
202
197
241
117
688
654
1,269
912
742
800
800
Total Equity
303
277
259
344
406
485
671
628
1,033
1,031
1,162
1,108
915
915
Return on Invested Capital (%)
11.82
11.28
16.09
23.98
12.08
14.26
11.31
-0.39
13.75
- -
- -
- -
- -
- -
Return on Capital (%)
12.1
11.72
16.07
21.41
12.71
14.03
11.63
0.51
15.13
- -
- -
- -
- -
- -
Return on Common Equity (%)
17.09
16.27
23.42
38.36
20.73
23.43
15.2
0.49
25.54
-3.19
-6.19
-6.48
-15.75
- -

Capital Structure

GBP

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
137
139
19
LT Borrowings
699
776
765
LT Finance Leases
44
45
35
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
163
163
164
Market Capitalization
261
182
105

Working Capital

GBP

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
826
834
689
Cash, Cash Equivalents & STI
226
266
190
Accounts Receivable, Net
156
242
95
Inventories
348
321
337
Total Current Liabilities
555
509
438
Payables & Accruals
- -
- -
- -
ST Debt
137
139
19
Deferred Revenue
- -
- -
- -

Growth Rates

GBP

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
15.74%
10.97%
-17.44%
Free Cash Flow
-12.4%
-79.61%
-129.49%
Net Income, GAAP
672.06%
1,349.49%
116.25%
Sales/Revenue/Turnover
8.59%
2.39%
-10.03%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
1,941
2024
- -
- -
1,933
2025
- -
- -
1,739

Semi-annual Earnings Per Share

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
-0.78
2024
- -
- -
-0.44
2025
- -
- -
-0.96

Semi-annual Dividends Per Share

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

CEO
Michael Willome
Full Time Employees
3,788
Sector
Process industries
Industry
Chemicals: specialty
Address
10 Greycoat Place London GL United Kingdom SW1P 1SB
IPO Date
Jan 7, 1986
Business
Synthomer plc is a specialty chemicals company that manufactures and supplies a broad portfolio of polymers and performance chemicals for industries including coatings, adhesives, medical, construction, functional polymers, performance materials and engineered particles; its core products encompass synthetic latexes such as acrylonitrile butadiene styrene latex and styrene butadiene latex, water-based polymer dispersions, thermoplastics, liquid polybutadienes, functional polymers and high-performance binders. The company operates production facilities primarily in Europe and Asia, serving global markets with tailored solutions for end-users in health and protection, performance materials, coatings and construction, and industry segments. Founded in 1860 and headquartered in London, UK, Synthomer maintains a strong focus on sustainability and innovation in its specialty chemical offerings. In recent developments, Synthomer has pursued strategic portfolio optimization, including the 2024 divestment of its acrylic dispersions business and site closures in Europe to streamline operations and enhance profitability amid challenging market conditions. The company also announced leadership changes and cost-saving measures in 2025, alongside ongoing efforts to grow its high-value functional polymers and engineered particles segments through targeted investments and customer partnerships.

Company News